CELLS OF THE IMMUNE-SYSTEM AND THEIR CYTOKINES IN EPIRETINAL MEMBRANES AND IN THE VITREOUS OF PATIENTS WITH PROLIFERATIVE DIABETIC-RETINOPATHY

被引:48
作者
TANG, S [1 ]
SCHEIFFARTH, OF [1 ]
THURAU, SR [1 ]
WILDNER, G [1 ]
机构
[1] UNIV MUNICH, HOSP EYE, IMMUNOL LAB, MATHILDENSTR 8, W-8000 MUNICH 2, GERMANY
关键词
PROLIFERATIVE DIABETIC RETINOPATHY; T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; HLA-DR ANTIGEN; LYMPHOKINES;
D O I
10.1159/000267287
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
In the present study, we specifically investigated the presence of the main immune cells, namely T helper/inducer lymphocytes, T suppressor/cytotoxic lymphocytes, B lymphocytes and macrophages, for HLA-DR antigen expression and the cytokines IL-1alpha and IL-2 in epiretinal membranes of proliferative diabetic retinopathy (PDR) using immunohistochemical staining. The levels of the two cytokines (IL-1alpha and IL-2) in the vitreous were measured by ELISA. The results show that 18 out of the 32 epiretinal specimens reacted positively with monoclonal anti-CD4 (marker for T helper/inducer cell subset) antibody (56%), 21 reacted with monoclonal anti-CD8 (marker for T suppressor/cytotoxic subset) antibody (66%), 15 reacted with monoclonal anti-CD22 (marker for B lymphocytes) antibody (47%), and 25 (78%) were positive for monoclonal anti-macrophage and anti-HLA-DR antibodies. IL-1alpha and IL-2 were detected in the epiretinal membranes in 8 out of 13 tested cases (62%). However, in the vitreous, IL-1alpha was detected in only 3 out of 13 cases (70, 75 and 80 pg/ml, respectively), while IL-2 was not detected in any of the vitreous samples. The results clearly demonstrate that immune cells and their cytokines were found in about half of the epiretinal membrane specimens. The invasion of the immunocompetent cells in the membranes seems to be a secondary event. They would not participate in the pathogenesis of PDR, but probably induce unspecific reactions and thus complicate the disease.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 35 条
[1]  
ATALLA L, 1990, INVEST OPHTH VIS SCI, V31, P1264
[2]   IMMUNOHISTOPATHOLOGIC FINDINGS IN PROLIFERATIVE DIABETIC-RETINOPATHY [J].
BAUDOUIN, C ;
FREDJREYGROBELLET, D ;
LAPALUS, P ;
GASTAUD, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 105 (04) :383-388
[3]   CLASS-II ANTIGEN EXPRESSION IN DIABETIC PRERETINAL MEMBRANES [J].
BAUDOUIN, C ;
GORDON, WC ;
FREDJREYGROBELLET, D ;
BAUDOUIN, F ;
PEYMAN, G ;
GASTAUD, P ;
BAZAN, NG .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (01) :70-74
[4]   INVIVO ANGIOGENIC ACTIVITY OF INTERLEUKINS [J].
BENEZRA, D ;
HEMO, I ;
MAFTZIR, G .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (04) :573-576
[5]  
BENEZRA D, 1990, Investigative Ophthalmology and Visual Science, V31, P194
[6]  
BENEZRA D, 1987, INVEST OPHTH VIS SCI, V28, P32
[7]  
DIGIOVINE FS, 1990, IMMUNOL TODAY, V11, P13
[8]  
DINARELLO CA, 1991, CYTOKINE HDB, P47
[9]   THE BIOCHEMISTRY, BIOLOGY, AND ROLE OF INTERLEUKIN-2 IN THE INDUCTION OF CYTO-TOXIC T-CELL AND ANTIBODY-FORMING B-CELL RESPONSES [J].
FARRAR, JJ ;
BENJAMIN, WR ;
HILFIKER, ML ;
HOWARD, M ;
FARRAR, WL ;
FULLERFARRAR, J .
IMMUNOLOGICAL REVIEWS, 1982, 63 :129-166
[10]  
FOX RI, 1985, J IMMUNOL, V135, P3109